Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ)
CNY 16.1
(-0.19%)
CNY 16.1
(-0.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.32 Billion CNY | 4.34% |
| 2022 | 1.27 Billion CNY | 22.37% |
| 2021 | 1.04 Billion CNY | 40.56% |
| 2020 | 740.63 Million CNY | 23.56% |
| 2019 | 599.39 Million CNY | 31.58% |
| 2018 | 455.54 Million CNY | 3.59% |
| 2017 | 439.77 Million CNY | -12.04% |
| 2016 | 499.96 Million CNY | 8.57% |
| 2015 | 460.51 Million CNY | 8.4% |
| 2014 | 424.82 Million CNY | 16.61% |
| 2013 | 364.3 Million CNY | 24.29% |
| 2012 | 293.1 Million CNY | 24.37% |
| 2011 | 235.67 Million CNY | 11.95% |
| 2010 | 210.51 Million CNY | 23.75% |
| 2009 | 170.1 Million CNY | 33.33% |
| 2008 | 127.58 Million CNY | 48.67% |
| 2007 | 85.81 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 428.77 Million CNY | -4.43% |
| 2024 Q3 | 365.37 Million CNY | -14.79% |
| 2024 Q1 | 448.67 Million CNY | 38.69% |
| 2023 Q1 | 346.4 Million CNY | 10.06% |
| 2023 Q4 | 323.51 Million CNY | 6.23% |
| 2023 Q3 | 304.55 Million CNY | -14.13% |
| 2023 Q2 | 354.67 Million CNY | 2.39% |
| 2023 FY | 1.32 Billion CNY | 4.34% |
| 2022 Q1 | 316.41 Million CNY | 16.88% |
| 2022 FY | 1.27 Billion CNY | 22.37% |
| 2022 Q4 | 314.72 Million CNY | -2.99% |
| 2022 Q3 | 324.42 Million CNY | 1.92% |
| 2022 Q2 | 318.31 Million CNY | 0.6% |
| 2021 FY | 1.04 Billion CNY | 40.56% |
| 2021 Q4 | 270.72 Million CNY | 1.28% |
| 2021 Q3 | 267.3 Million CNY | 4.79% |
| 2021 Q2 | 255.09 Million CNY | 2.9% |
| 2021 Q1 | 247.91 Million CNY | 22.86% |
| 2020 FY | 740.63 Million CNY | 23.56% |
| 2020 Q3 | 218.72 Million CNY | 15.52% |
| 2020 Q1 | 130.79 Million CNY | -24.27% |
| 2020 Q2 | 189.33 Million CNY | 44.76% |
| 2020 Q4 | 201.78 Million CNY | -7.75% |
| 2019 Q2 | 146.8 Million CNY | 14.26% |
| 2019 FY | 599.39 Million CNY | 31.58% |
| 2019 Q3 | 151.38 Million CNY | 3.12% |
| 2019 Q4 | 172.71 Million CNY | 14.09% |
| 2019 Q1 | 128.48 Million CNY | 9.41% |
| 2018 Q3 | 81.12 Million CNY | -45.33% |
| 2018 FY | 455.54 Million CNY | 3.59% |
| 2018 Q2 | 148.37 Million CNY | 36.63% |
| 2018 Q4 | 117.43 Million CNY | 44.76% |
| 2018 Q1 | 108.6 Million CNY | 1.64% |
| 2017 Q4 | 106.85 Million CNY | 30.72% |
| 2017 Q3 | 81.74 Million CNY | -41.37% |
| 2017 Q1 | 111.76 Million CNY | -0.17% |
| 2017 FY | 439.77 Million CNY | -12.04% |
| 2017 Q2 | 139.41 Million CNY | 24.75% |
| 2016 Q2 | 168.71 Million CNY | 30.24% |
| 2016 FY | 499.96 Million CNY | 8.57% |
| 2016 Q4 | 111.95 Million CNY | 24.75% |
| 2016 Q1 | 129.54 Million CNY | 18.89% |
| 2016 Q3 | 89.74 Million CNY | -46.81% |
| 2015 Q4 | 108.95 Million CNY | -0.12% |
| 2015 FY | 460.51 Million CNY | 8.4% |
| 2015 Q3 | 109.08 Million CNY | -12.08% |
| 2015 Q2 | 124.07 Million CNY | 4.8% |
| 2015 Q1 | 118.39 Million CNY | -6.98% |
| 2014 Q4 | 127.27 Million CNY | 24.37% |
| 2014 Q3 | 102.33 Million CNY | -1.87% |
| 2014 FY | 424.82 Million CNY | 16.61% |
| 2014 Q1 | 90.92 Million CNY | -8.32% |
| 2014 Q2 | 104.29 Million CNY | 14.7% |
| 2013 Q4 | 99.17 Million CNY | 8.06% |
| 2013 FY | 364.3 Million CNY | 24.29% |
| 2013 Q3 | 91.77 Million CNY | -3.29% |
| 2013 Q2 | 94.89 Million CNY | 20.92% |
| 2013 Q1 | 78.47 Million CNY | -0.46% |
| 2012 Q4 | 78.83 Million CNY | 0.44% |
| 2012 Q3 | 78.49 Million CNY | 6.85% |
| 2012 Q2 | 73.45 Million CNY | 17.87% |
| 2012 FY | 293.1 Million CNY | 24.37% |
| 2012 Q1 | 62.32 Million CNY | -8.95% |
| 2011 Q3 | 60.43 Million CNY | -5.97% |
| 2011 Q1 | 42.51 Million CNY | -31.08% |
| 2011 Q2 | 64.27 Million CNY | 51.17% |
| 2011 Q4 | 68.44 Million CNY | 13.26% |
| 2011 FY | 235.67 Million CNY | 11.95% |
| 2010 FY | 210.51 Million CNY | 23.75% |
| 2010 Q4 | 61.68 Million CNY | 12.94% |
| 2010 Q2 | 64.49 Million CNY | 117.07% |
| 2010 Q3 | 54.61 Million CNY | -15.31% |
| 2010 Q1 | 29.71 Million CNY | 0.0% |
| 2009 FY | 170.1 Million CNY | 33.33% |
| 2008 FY | 127.58 Million CNY | 48.67% |
| 2007 FY | 85.81 Million CNY | 0.0% |